Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Glaucoma
Interventions
DRUG

Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)

Brinzolamide/timolol maleate fixed combination, one drop instilled in one eye at baseline, followed by one drop instilled in each eye once in either first intervention period or second intervention period.

DRUG

Dorzolamide/timolol Maleate Fixed Combination (COSOPT)

Dorzolamide/timolol maleate fixed combination, one drop instilled in one eye at baseline, followed by one drop instilled in each eye once in either first intervention period or second intervention period.

Trial Locations (1)

1425

Centro Oftalmológico, Buenos Aires

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY